Costs and Consequences of Using Interferon- Release Assays for the Diagnosis of Active Tuberculosis in India

Nav

General Info

Geography

India (IND)

Coverage type

Country

Time period covered

01/2013 - 12/2013

Data type

Scientific literature

Keywords

DALYs, Diagnostic equipment, Health care costs, Health care economics, Health care expenditures, Tuberculosis

Citation

Authors

Little KM, Pai M, Dowdy DW

Journal

PLoS One

Volume

Issue

Pages

e0124525

Publication year

2014

Suggested citation

Little KM, Pai M, Dowdy DW. Costs and Consequences of Using Interferon- Release Assays for the Diagnosis of Active Tuberculosis in India. PLoS One. 2014; 10(4): e0124525.

DOI

10.1371/journal.pone.0124525

PMID

25918999

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

Costs and Consequences of Using Interferon- Release Assays for the Diagnosis of Active Tuberculosis in India

Nav